[Recurrent urinary tract infections: prevention of recurrence with intravesical instillations of chondroitin sulfate and hyaluronic acid]
- PMID: 28300032
[Recurrent urinary tract infections: prevention of recurrence with intravesical instillations of chondroitin sulfate and hyaluronic acid]
Abstract
Objective: The aim of our study is to demonstrate that intravesical administration of the association chondroitin sulfate (CS) and hyaluronic acid (HA), according to our treatment schedule, is a benefit for women with recurrent urinary tract infections (RUTI), not only from a clinical point of view, but also reducing recurrences.
Methods: This is a study of 28 women diagnosed with RUTI, with a positive culture, and compatible symptoms;frethey underwent treatment according to the protocol of intravesical instillations of the combination CS 2%-1 gr + HA 1.6%-800 mg. To evaluate the effectiveness of the treatment, symptoms improvement, reduction of the number of episodes of urinary tract infection and quality of life were considered.
Results: In our series, we can observe an improvement of the quality of life assessed by PG-I, 66% after 12 months. It was seen that 55.6% of the patient's urine cultures became negative, while 44.4% had episodes of urinary infection, but with lower baseline symptoms intensity.
Discussion: Patients included in the protocol of instillation improved significantly their quality of life; in addition, to a considerable extent new urinary infections were not presented, being milder when they presented.
Similar articles
-
Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study.BMJ Open. 2016 Mar 31;6(3):e009669. doi: 10.1136/bmjopen-2015-009669. BMJ Open. 2016. PMID: 27033958 Free PMC article.
-
Is intravesical instillation of hyaluronic acid and chondroitin sulfate useful in preventing recurrent bacterial cystitis? A multicenter case control analysis.Taiwan J Obstet Gynecol. 2015 Oct;54(5):537-40. doi: 10.1016/j.tjog.2015.03.005. Taiwan J Obstet Gynecol. 2015. PMID: 26522106
-
Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial.Eur Urol. 2011 Apr;59(4):645-51. doi: 10.1016/j.eururo.2010.12.039. Epub 2011 Jan 18. Eur Urol. 2011. PMID: 21272992 Clinical Trial.
-
Intravesical Agents for Prevention of Recurrent Urinary Tract Infections.Eur Urol Focus. 2024 Sep;10(5):726-730. doi: 10.1016/j.euf.2024.08.001. Epub 2024 Aug 19. Eur Urol Focus. 2024. PMID: 39164132 Review.
-
New preclinical data - the case for Ialuril®.Urologia. 2016 Jun 25;83 Suppl 1:15-9. doi: 10.5301/uro.5000185. Epub 2016 Jun 23. Urologia. 2016. PMID: 27405345 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials